🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has removed violative material and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for mixing or injecting at home.

After moments of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Item Details and Pricing

Within these groups, posts display black plastic parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously seen individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant health risks”.